Table III.
Significant univariate associations between antimicrobial resistances (P > 0.007), (n = 1439)
| Variable
|
||||
|---|---|---|---|---|
| Outcome | Predictor | Odds ratio | 95% Confidence Interval | P |
| Ampicillin | Kanamycin | 3.1 | 1.6–6.0 | 0.001 |
| Streptomycin | 2.0 | 1.2–3.1 | 0.004 | |
| Tetracycline | 2.5 | 1.8–3.5 | ≤ 0.001 | |
| Sulfamethoxazole | 2.3 | 1.4–3.7 | ≤ 0.001 | |
| Trimethoprim-sulfamethoxazole | 5.7 | 2.6–12.6 | ≤ 0.001 | |
| Chloramphenicol | Sulfamethoxazole | 34.6 | 12.6–95 | ≤ 0.001 |
| Trimethoprim-sulfamethoxazole | 3.3 | 1.7–6.4 | ≤ 0.001 | |
| Kanamycin | Ampicillin | 2.8 | 1.5–5.2 | 0.001 |
| Streptomycin | 4.2 | 1.9–8.9 | ≤ 0.001 | |
| Sulfamethoxazole | 5.9 | 3.2–10.9 | ≤ 0.001 | |
| Trimethoprim-sulfamethoxazole | 1.4 | 1.1–1.7 | 0.005 | |
| Streptomycin | Ampicillin | 2.1 | 1.3–3.4 | 0.002 |
| Kanamycin | 5.2 | 2.1–12.5 | ≤ 0.001 | |
| Tetracycline | 5.6 | 3.9–7.9 | ≤ 0.001 | |
| Sulfamethoxazole | 2.7 | 1.9–3.8 | ≤ 0.001 | |
| Sulfamethoxazole | Ampicillin | 2.2 | 1.4–3.5 | 0.001 |
| Kanamycin | 5.6 | 2.7–11.5 | ≤ 0.001 | |
| Streptomycin | 2.4 | 1.8–3.2 | ≤ 0.001 | |
| Tetracycline | 2.9 | 1.9–4.5 | ≤ 0.001 | |
| Trimethoprim-sulfamethoxazole | 118 | 14–968 | ≤ 0.001 | |
| Chloramphenicol | 31 | 13–73 | ≤ 0.001 | |
| Tetracycline | Ampicillin | 2.3 | 1.7–3.2 | ≤ 0.001 |
| Streptomycin | 4.6 | 3.3–6.5 | ≤ 0.001 | |
| Sulfamethoxazole | 3.1 | 2.1–4.7 | ≤ 0.001 | |
| Trimethoprim-sulfamethoxazole | Ampicillin | 6.5 | 3.0–14.2 | ≤ 0.001 |
| Sulfamethoxazole | 215 | 9.0–5170 | ≤ 0.001 | |
| Chloramphenicol | 3.6 | 1.8–7.2 | ≤ 0.001 | |